Join
Live feed
·
INSIDERFilingvia Quantisnow
Abeona Therapeutics Inc. logo

Chief Commercial Officer Vasanthavada Madhav sold $51,549 worth of shares (9,620 units at $5.36), decreasing direct ownership by 3% to 303,451 units (SEC Form 4) to satisfy withholding obligation

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ABEO (Abeona Therapeutics Inc.) and more on Quantisnow.